e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stable state MR-proadrenomedullin level in COPD patients; a validation study
M. Zuur-Telgen, P. vanderValk, J. van der Palen, H. Kerstjens, M. Brusse-Keizer (Enschede, Groningen, Netherlands)
Source:
International Congress 2014 – Comorbidities
Session:
Comorbidities
Session type:
Thematic Poster Session
Number:
3608
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Zuur-Telgen, P. vanderValk, J. van der Palen, H. Kerstjens, M. Brusse-Keizer (Enschede, Groningen, Netherlands). Stable state MR-proadrenomedullin level in COPD patients; a validation study. Eur Respir J 2014; 44: Suppl. 58, 3608
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014
Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Is clinical presentation different between men and women with COPD?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Adrenomedullin optimizes mortality prediction in COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept